FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3204865263> ?p ?o ?g. }

• W3204865263 abstract "This review aims to assess the benefits and adverse effects of sacubitril/valsartan in heart failure, with a focus on important patient outcomes. A systematic review was conducted of double-blind randomized controlled trials (RCTs) comparing sacubitril/valsartan versus a reference drug, in heart failure patients with reduced (HFrEF) and preserved (HFpEF) ejection fraction, published in French or English. Searches were undertaken of Medline, Cochrane Central, and Embase. The primary outcomes were all-cause mortality and adverse events. From 2 082 articles analyzed, 5 were included. For all-cause mortality, the absolute numbers for HFrEF (2 RCTs, 4627 patients) were 16% on sacubitril/valsartan and 18% on enalapril, with a risk ratio (RR) of 0.85 [CI = 0.78, 0.93], and 13% vs 14% in with HFpEF (2 RCTs, 5097 patients), with no statistical difference. Under the Grading of Recommendations Assessment, Development and Evaluation (GRADE) approach, the evidence for HFrEF patients was of moderate quality. For HFrEF patients, an increased risk of symptomatic hypotension and angioedema (low quality of evidence) was shown. There was no statistical difference for the risk of hyperkalemia or worsening renal function. There was a protective RR (0.50 [0.34, 0.75]) for worsening renal function for patients with HFpEF, with a high quality of evidence despite similar absolute numbers (1.4% vs. 2.8%). To keep in mind for shared decision-making, sacubitril/valsartan reduces all-cause mortality in HFrEF patients but for HFpEF further data are needed. Take into consideration the small number of studies to date to assess the risks." @default.
• W3204865263 created "2021-10-11" @default.
• W3204865263 creator A5020688995 @default.
• W3204865263 creator A5030020327 @default.
• W3204865263 creator A5048053718 @default.
• W3204865263 creator A5049031139 @default.
• W3204865263 creator A5054080034 @default.
• W3204865263 creator A5064051090 @default.
• W3204865263 creator A5080749717 @default.
• W3204865263 creator A5082506046 @default.
• W3204865263 creator A5083774281 @default.
• W3204865263 date "2021-10-01" @default.
• W3204865263 modified "2023-10-13" @default.
• W3204865263 title "Benefits and adverse effects of sacubitril/valsartan in patients with chronic heart failure: A systematic review and meta‐analysis" @default.
• W3204865263 cites W1966326628 @default.
• W3204865263 cites W2023992279 @default.
• W3204865263 cites W2032130572 @default.
• W3204865263 cites W2094643652 @default.
• W3204865263 cites W2104675861 @default.
• W3204865263 cites W2109346853 @default.
• W3204865263 cites W2113698123 @default.
• W3204865263 cites W2143094666 @default.
• W3204865263 cites W2150427176 @default.
• W3204865263 cites W2156098321 @default.
• W3204865263 cites W2341907313 @default.
• W3204865263 cites W2427094903 @default.
• W3204865263 cites W246286872 @default.
• W3204865263 cites W2588681363 @default.
• W3204865263 cites W2617287176 @default.
• W3204865263 cites W2771328536 @default.
• W3204865263 cites W2899841238 @default.
• W3204865263 cites W2916841405 @default.
• W3204865263 cites W2920977137 @default.
• W3204865263 cites W2970357473 @default.
• W3204865263 cites W2970684805 @default.
• W3204865263 cites W2971294569 @default.
• W3204865263 cites W3029477868 @default.
• W3204865263 cites W3087233735 @default.
• W3204865263 cites W3088122434 @default.
• W3204865263 cites W3089164223 @default.
• W3204865263 cites W3109335265 @default.
• W3204865263 cites W4294215472 @default.
• W3204865263 doi "https://doi.org/10.1002/prp2.844" @default.
• W3204865263 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/8495680" @default.
• W3204865263 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/34617669" @default.
• W3204865263 hasPublicationYear "2021" @default.
• W3204865263 type Work @default.
• W3204865263 sameAs 3204865263 @default.
• W3204865263 citedByCount "8" @default.
• W3204865263 countsByYear W32048652632022 @default.
• W3204865263 countsByYear W32048652632023 @default.
• W3204865263 crossrefType "journal-article" @default.
• W3204865263 hasAuthorship W3204865263A5020688995 @default.
• W3204865263 hasAuthorship W3204865263A5030020327 @default.
• W3204865263 hasAuthorship W3204865263A5048053718 @default.
• W3204865263 hasAuthorship W3204865263A5049031139 @default.
• W3204865263 hasAuthorship W3204865263A5054080034 @default.
• W3204865263 hasAuthorship W3204865263A5064051090 @default.
• W3204865263 hasAuthorship W3204865263A5080749717 @default.
• W3204865263 hasAuthorship W3204865263A5082506046 @default.
• W3204865263 hasAuthorship W3204865263A5083774281 @default.
• W3204865263 hasBestOaLocation W32048652632 @default.
• W3204865263 hasConcept C126322002 @default.
• W3204865263 hasConcept C164705383 @default.
• W3204865263 hasConcept C168563851 @default.
• W3204865263 hasConcept C177713679 @default.
• W3204865263 hasConcept C197934379 @default.
• W3204865263 hasConcept C27016395 @default.
• W3204865263 hasConcept C2775940317 @default.
• W3204865263 hasConcept C2775999527 @default.
• W3204865263 hasConcept C2776754050 @default.
• W3204865263 hasConcept C2777099384 @default.
• W3204865263 hasConcept C2777387769 @default.
• W3204865263 hasConcept C2778198053 @default.
• W3204865263 hasConcept C71924100 @default.
• W3204865263 hasConcept C78085059 @default.
• W3204865263 hasConcept C84393581 @default.
• W3204865263 hasConceptScore W3204865263C126322002 @default.
• W3204865263 hasConceptScore W3204865263C164705383 @default.
• W3204865263 hasConceptScore W3204865263C168563851 @default.
• W3204865263 hasConceptScore W3204865263C177713679 @default.
• W3204865263 hasConceptScore W3204865263C197934379 @default.
• W3204865263 hasConceptScore W3204865263C27016395 @default.
• W3204865263 hasConceptScore W3204865263C2775940317 @default.
• W3204865263 hasConceptScore W3204865263C2775999527 @default.
• W3204865263 hasConceptScore W3204865263C2776754050 @default.
• W3204865263 hasConceptScore W3204865263C2777099384 @default.
• W3204865263 hasConceptScore W3204865263C2777387769 @default.
• W3204865263 hasConceptScore W3204865263C2778198053 @default.
• W3204865263 hasConceptScore W3204865263C71924100 @default.
• W3204865263 hasConceptScore W3204865263C78085059 @default.
• W3204865263 hasConceptScore W3204865263C84393581 @default.
• W3204865263 hasIssue "5" @default.
• W3204865263 hasLocation W32048652631 @default.
• W3204865263 hasLocation W32048652632 @default.
• W3204865263 hasLocation W32048652633 @default.
• W3204865263 hasLocation W32048652634 @default.
• W3204865263 hasLocation W32048652635 @default.
• W3204865263 hasLocation W32048652636 @default.
• W3204865263 hasLocation W32048652637 @default.

• next